Results 311 to 320 of about 212,775 (379)

Von Willebrand Factor Activity Association With Outcomes After Transcatheter Edge-to-Edge Mitral Valve Repair. [PDF]

JACC Adv
Hadjadj S, Pibarot P, Gravel C, Clavel MA, Marsit O, Rouabhia D, Labbé BM, O'Connor K, Bernier M, Salaun E, Farjat J, Nuche Berenguer J, Rodés-Cabau J, Paradis JM, Beaudoin J.   +14 more
europepmc   +1 more source

Carbamylation-A Pathologic Posttranslational Modification Affecting Platelet and Von Willebrand Factor Function during Uremic Kidney Disease. [PDF]

Thromb Haemost
Koenen RR.
europepmc   +1 more source

Von Willebrand Factor Antigen, Biomarkers of Inflammation, and Microvascular Flap Thrombosis in Reconstructive Surgery. [PDF]

J Clin Med
Rocans RP, Zarins J, Bine E, Mahauri I, Deksnis R, Citovica M, Donina S, Vanags I, Gravelsina S, Vilmane A, Rasa-Dzelzkaleja S, Mamaja B.   +11 more
europepmc   +1 more source

The impact of hsa-miR-1972 on the expression of von Willebrand factor in breast cancer progression regulation. [PDF]

PeerJ
Yu C, Zhang T, Chen F, Yu Z.
europepmc   +1 more source

Cooperation between coagulase and von willebrand factor binding protein in Staphylococcus aureus fibrin pseudocapsule formation. [PDF]

Biofilm
Evans DCS, Khamas AB, Payne-Dwyer A, Wollman AJM, Rasmussen KS, Klitgaard JK, Kallipolitis B, Leake MC, Meyer RL.   +8 more
europepmc   +1 more source

Plasma Levels of ADAMTS-13 Antigen, ADAMTS-13 Inhibitor, ADAMTS-13 Activity, and Von Willebrand Factor in Patients with Behçet's Disease. [PDF]

Mediterr J Rheumatol
Karasu U, Erkek M, Ulutaş F, Demiray A, Çimen Y, Kaymaz S, Açıkbaş İ, Şenol H, Çobankara V.   +8 more
europepmc   +1 more source

Ex vivo evaluation of the effect of plasma-derived factor VIII/von Willebrand factor in patients with severe hemophilia A on emicizumab prophylaxis. [PDF]

Clin Exp Med
Raventós A, Arias-Salgado EG, Pérez A, Alvarez-Román MT, Butta NV, Monzon Manzano E, Acuña P, Jiménez-Yuste V, Costa M, Bravo MI.   +9 more
europepmc   +1 more source

Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls/women with von Willebrand disease. [PDF]

AJOG Glob Rep
Kiss C, Boda Z, Khayat CD, Boban A, Dubey L, Sidonio RF.   +5 more
europepmc   +1 more source

Efficacy and safety of plasma-derived von Willebrand factor/factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease - WIL-31 study post hoc analysis. [PDF]

Res Pract Thromb Haemost
Sidonio RF, Dubey L, Vilchevska KV, Inati A, Djambas Khayat C.   +4 more
europepmc   +1 more source

Von Willebrand Factor Dynamics in Patients with Aortic Stenosis Undergoing Surgical and Transcatheter Valve Replacement. [PDF]

Life (Basel)
Grigorescu AE, Anghel A, Koch C, Horhat FG, Savescu D, Feier H.   +5 more
europepmc   +1 more source